Xu Song
Identity
· Associate Professor
Education
· 09/2009-12/2015, PhD in Basic Veterinary Medicine, Sichuan Agricultural University
· 09/2005-06/2009, B.S. in Pharmaceutical Engineering, Sichuan Agricultural University
Training and Professional Experience
· 2022-now, Associate Professor, Sichuan Agricultural University College of Veterinary Medicine
· 2016-2021, Assistant professor, Sichuan Agricultural University College of Veterinary Medicine
Research Interests
· Focus on antiviral drugs.
Selected Publications
· Xu Song, Lin Liu, Shuwei Peng, Tao Liu, Yaqin Chen, Renyong Jia, Yuanfeng Zou, Lixia Li, Xinghong Zhao, Xiaoxia Liang, Huaqiao Tang, and Zhongqiong Yin*. Resveratrol Regulates Intestinal Barrier Function in Cyclophosphamide-Induced Immunosuppressed Mice. Journal of the Science of Food and Agriculture, 2022,102(3): 1205-1215.
· Xu Song, Lin Liu, Wei Hu, Xiaoxia Liang, Changliang He, Lizi Yin, Gang Ye, Yuanfeng Zou, Lixia Li, Huaqiao Tang, Renyong Jia, Zhongqiong Yin*. Identification of the amino acids residues involved in hemagglutinin neuraminidase of Newcastle disease virus binding to sulfated Chuanmingshen violaceum polysaccharides. Poultry Science, 2021, 100: 101255.
· Xu Chen, Yaqin Chen, Zhongqiong Yin, Rui Wang, Huaiyue Hu, Xiaoxia Liang, Changliang He, Lizi Yin, Gang Ye, Yuanfeng Zou, Lixia Li, Huaqiao Tang, Renyong Jia, Xu Song*. Kaempferol inhibits Pseudorabies virus replication in vitro through regulation of MAPKs and NF-κB signaling pathways. Journal of Integrative Agriculture, 2021, 20(8): 2227-2239.
· Lixia Li, Rui Wang, Huaiyue Hu, Xu Chen, Zhongqiong Yin, Xiaoxia Liang, Changliang He, Lizi Yin, Gang Ye, Yuanfeng Zou, Guizhou Yue, Huaqiao Tang, Renyong Jia, Xu Song*. The antiviral activity of kaempferol against pseudorabies virus in mice. BMC Veterinary Research, 2021, 17: 247.
· Xu Song, Yi Yang, Junzhi Li, Mengxue He, Yuanfeng Zou, Renyong Jia, Lixia Li, Juan Hang, Min Cui, Lu Bai, and Zhongqiong Yin*. “Tannins Extract from Galla Chinensis Can Protect Mice from Infection by Enterotoxigenic Escherichia Coli O101.” BMC Complementary Medicine and Therapies, 2021, 21(1):1–10.